Skip to main content
. 2022 Jan 31;12(1):21. doi: 10.1038/s41408-022-00611-x

Fig. 2. PFS and OS based on the MASS using the Mayo Clinic cohort.

Fig. 2

a PFS (months) and b OS (years) in MM patients with no HR factors (stage I) (red curve), 1 HR factor (stage II) (green curve), and ≥2 HR factors (stage III) (blue curve). HR factors are defined as any of: HR IgH translocations, 1q gain/amplification, chromosome 17 abnormality [(del)17p/monosomy 17], ISS stage III, and LDH > ULN. del: deletion, HR: high-risk, IgH immunoglobulin heavy chain gene locus, ISS international staging system, LDH lactate dehydrogenase, MASS Mayo Additive Staging System, MM multiple myeloma, OS overall survival, PFS progression-free survival, ULN upper limit of normal. The P values for each pair of groups are presented between the corresponding curves.